KLRK1 Antikörper
Kurzübersicht für KLRK1 Antikörper (ABIN7091315)
Target
Alle KLRK1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Kreuzreaktivität
- Maus
-
Homologie
- Rat
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from mouse NKG2D
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF()
ICC 1:100-500 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- KLRK1 (Killer Cell Lectin-Like Receptor Subfamily K, Member 1 (KLRK1))
-
Andere Bezeichnung
- NKG2D
-
Hintergrund
-
Synonyms: KLRK1, natural killer cell group 2D, NKG2-D isoform b, Klrk1, Nkrp2, NKG2-D type II integral membrane protein, NKG2-D-activating NK receptor, NK cell receptor D, Killer cell lectin-like receptor subfamily K, NK lectin-like receptor, CD314, CD 314, CD314 antigen, D12S2489E, Killer cell lectin like receptor subfamily K member 1, Killer cell lectin-like receptor subfamily K member 1, KLR, Klrk1, NKG2 D activating NK receptor, NKG2 D type II integral membrane protein, NKG2-D-activating NK receptor, NKG2D_HUMAN, NKLLR, NKR P2, Nkrp2.
Background: Receptor for MICA, MICB, ULBP1, ULBP2, ULBP3 (ULBP2>ULBP1>ULBP3) and ULBP4. Plays a role as a receptor for the recognition of MHC class I HLA-E molecules by NK cells and some cytotoxic T-cells. Involved in the immune surveillance exerted by T- and B-lymphocytes.
-
Gen-ID
- 27007
-
UniProt
- O54709
-
Pathways
- Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
Target
-